In today’s fast-paced lifestyle, digestive issues such as constipation, gas, and acidity have become increasingly common due ...

The latest announcement is out from Abivax SA Sponsored ADR ( (ABVX) ).

NDA for icotrokinra for the treatment of adults and adolescents 12 years of age and older with moderate to severe plaque ...

Abivax SA (NASDAQ:ABVX) shares surged in post-market trading Tuesday after the French biotech firm announced successful Phase 3 trial results for its ulcerative colitis treatment, obefazimod. The oral ...

TUESDAY, August 5, 2025 (HealthDay News) — C. diff, which is short for Clostridioides difficile, is a type of bacteria that ...

Abivax has shared positive top-line results from two late-stage studies of its investigational oral miR-124 enhancer in ...

The interaction between a common gene variant and gut microbes may trigger chronic inflammation in ulcerative colitis, new research suggests.

Mesheal Garrett, the suspect’s other son, said that she was attentive to his brother’s medical needs and had been seeking holistic treatments.

C. diff, which is short for Clostridioides difficile, is a type of bacteria that may cause serious problems in the digestive ...

A majority of patients with inflammatory bowel disease (IBD) said they felt marijuana and CBD were “beneficial” and provided ...

An acute gastroenteritis outbreak is affecting members of the U.S. swim team at Worlds. Here’s what it means, what causes it, ...

Alfasigma is in discussions with the EMA and MHRA about Jyseleca for axSpA but has yet to reveal any plans for US submission.